Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif containing 44 (TRIM44) is a member of the TRIM protein family, distinguished by its conserved domains including zinc finger, B-box, coiled-coil, and glutamate-rich regions[1][2]. Unlike canonical TRIM proteins, TRIM44 lacks a RING domain, separating it from classic E3 ligases; however, it functions as a deubiquitinase and protein quality control factor[2]. TRIM44 links the ubiquitin-proteasome system with autophagy by promoting SQSTM1/p62 oligomerization, supporting the removal of misfolded or aggregated proteins through targeting them for autophagic degradation[1]. It is upregulated in multiple myeloma and other aggregate-prone diseases, where it can promote cell survival and pathological changes such as bone destruction[1]. TRIM44 also plays a role in DNA damage response by interacting with PARP1 and the ATM/MRN complex, dictating cell sensitivity to PARP inhibitors and coordinating double-strand break repair[2]. Thus, TRIM44 is a multifunctional regulatory protein at the crossroads of proteostasis, autophagy, and DNA repair, making it a candidate therapeutic target in cancers and neurodegenerative diseases.
Modulation of autophagy and proteasome pathway activity; Regulation of DNA damage response signaling via PARP1 and ATM/MRN complex; Promotion of SQSTM1/p62 oligomerization and aggregate clearance; Influencing cell sensitivity/resistance to proteasome and PARP inhibition.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif containing 44 (TRIM44).